TRPV1 and colitis: If 5-ASA blocks toxin A colitis by inhibiting the generation of an endogenous TRPV1 agonist such as LTB4, we reasoned that 5-ASA pretreatment should not inhibit colitis caused by an agent that directly stimulates TRPV1.